Compound ID | 1613

Novel Phloroglucinol Derivative 11

Spectrum of activity: Gram-positive
Details of activity: Staphylococcus aureus
Institute where first reported: University of Manitoba, Canada
Year first mentioned: 2019
Highest developmental phase: Preclinical

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.